Immune-mediated acquired lecithin-cholesterol acyltransferase deficiency: A case report and literature review-Reference-Cited by-同舟云学术

Immune-mediated acquired lecithin-cholesterol acyltransferase deficiency: A case report and literature review

Published:2018-07 Issue:4 Volume:12 Page:888-897.e2
ISSN:1933-2874
Container-title:Journal of Clinical Lipidology
language:en
Short-container-title:Journal of Clinical Lipidology

Author:

Ishibashi Ryoichi,Takemoto Minoru,Tsurutani Yuya,Kuroda Masayuki,Ogawa Makoto,Wakabayashi Hanae,Uesugi Noriko,Nagata Michio,Imai Naofumi,Hattori Akiko,Sakamoto Kenichi,Kitamoto Takumi,Maezawa Yoshiro,Narita Ichiei,Hiroi Sadayuki,Furuta Ayaka,Miida Takashi^ORCID,Yokote Koutaro

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference25 articles.

1. The mechanism of the plasma cholesterol esterification reaction: plasma fatty acid transferase;Glomset;Biochim Biophys Acta,1962

2. Renal failure in familial lecithin-cholesterol acyltransferase deficiency;Myhre;Nephron,1977

3. Lipoprotein subfractions highly associated with renal damage in familial lecithin:cholesterol acyltransferase deficiency;Kuroda;Arterioscler Thromb Vasc Biol,2014

4. Nephrotic syndrome caused by immune-mediated acquired LCAT deficiency;Takahashi;J Am Soc Nephrol,2013

5. (in Japanese);Sato;Therapeutic Research,2000

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nephrotic syndrome: pathophysiology and consequences;Journal of Nephrology;2023-07-19

2. Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022;Journal of Atherosclerosis and Thrombosis;2023

3. First-in-human autologous implantation of genetically modified adipocytes expressing LCAT for the treatment of familial LCAT deficiency;Heliyon;2022-11

4. LCAT- targeted therapies: Progress, failures and future;Biomedicine & Pharmacotherapy;2022-03

5. Two Cases of Acquired High-Density Lipoprotein Deficiency with Immunoglobulin G4-Related Lecithin–Cholesterol Acyltransferase Autoantibody;Journal of Atherosclerosis and Thrombosis;2022